leadf
logo-loader
viewHeartseed

Heartseed developing heart failure treatment

Heartseed Inc CEO Keiichi Fukuda sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Tokyo-based biotechnology company is developing a treatment for heart failure, and recently raised $26M in Series B funding.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Gatling Exploration connects all three high-grade gold deposits at Larder...

Gatling Exploration (CVE: GTR-OTCQB: GATGF) Vice President of Exploration Nathan Tribble shared news with Steve Darling from Proactive Vancouver that Gatling has been able to connect a continuous 4.5 km gold strike at their Larder Project. Tribble explains how they were able to do that,...

1 hour, 51 minutes ago

2 min read